NexMetals upgrades Selkirk copper resource to 1.1B lb.

NexMetals Mining said its Selkirk copper-nickel-PGE project in Botswana now has about 1.1 billion lb. copper equivalent (CuEq) in indicated resources after converting nearly 70% from inferred, driven by re-assaying and twin drilling. NexMetals reported 78.2 million tonnes at 0.66% CuEq, plus 15.1 million inferred tonnes at 0.60% CuEq. The upgrade raises contained CuEq inventory 63% vs. 2024, mainly from improved recoveries and adding payable cobalt, silver and gold.

Original reporting
Published Jun 26, 2026, 7:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 26, 2026, 8:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$NEXM
Bullish
medium confidence
Mentioned
$NEXM
Relevance
7/10
AlphAI data visualization · based on mining.com
Decision brief

The 30-second read

$NEXMBullishMed
01

Why it matters

The Selkirk resource update converts inferred to indicated via re-assaying and twin drilling, raising contained CuEq inventory by 63% and adding payable cobalt, silver, and gold to the inventory mix.

02

Market read

A concrete resource conversion and inventory increase can re-rate a microcap’s risk profile, but the stock’s partial giveback suggests broader metals tape still constrains follow-through.

03

What to watch

The article notes metal price changes had minimal net impact versus 2024, implying the key driver is conversion/recoveries—traders may still discount near-term value until capex/grade-to-recovery and payable metal assumptions are validated.

Relevance 7/10Novelty 6/10Timing: on the day of the Selkirk resource update and immediate post-news trading reaction

Background

NexMetals is redeveloping the Selebi and Selkirk past-producing copper-cobalt-nickel mines in Botswana after acquiring them out of liquidation in 2022.

Company-level read

Ticker impact

$NEXMBullishMedium confidence
Context

NexMetals upgraded its Selkirk copper-nickel-PGE resource to ~1.1B lb CuEq, converting inferred to indicated and boosting inventory 63%.

Expected impact

Likely near-term positive bias, though follow-through depends on continued metal price weakness and subsequent drilling/feasibility milestones.

Evidence & confidence

The article provides concrete resource tonnage/grade, category conversion, and a stated 63% inventory increase, plus notes the stock initially jumped ~10% then faded.

Market effects

Supports sentiment for polymetallic copper/cobalt/nickel development stories where resource confidence and recoveries improve financing optionality.

Botswana-focused critical metals narrative may attract incremental attention to local project pipelines.

Adds incremental supply-side optionality to copper-equivalent inventories, but scale is small versus global markets.

Counterpoint

A resource upgrade can be largely technical; without updated economics (PFS/FS) and permitting timelines, the market may fade the initial enthusiasm.

Key entities

  • NexMetals Mining

    Upgraded Selkirk copper-nickel-PGE resource to ~1.1B lb CuEq indicated, citing improved recoveries and re-assaying/twin drilling.

  • Selkirk project (Botswana)

    Mining licence ~14.6 sq. km; resource upgrade positions it as a strategically important multi-commodity critical metals asset.

Related articles

$NEXMMed

NexMetals Reports 72% Increase in Selebi Main Inferred Resource to 32.47 Mt

NexMetals reported a 72% increase in the Selebi Main inferred mineral resource to 32.47 Mt, with grades of 1.53% Cu and 0.98% Ni. Contained metal increased by 55% for Cu and 91% for Ni compared to 2024. The growth was primarily driven by new drilling in the Flexure Zone. The company used US$5.10/lb for Cu and US$9.10/lb for Ni in its estimates. The Selebi North MRE will be reported separately.

$NEXMMedAI 9/10

NexMetals Mining Corp.: NexMetals' Final Analytical Results Confirm Selkirk Copper and Nickel Clean Concentrates Meet Commercial Smelter Specifications

NexMetals Mining Corp. said final metallurgical analytical results from Selkirk Mine in Botswana confirm its copper and nickel concentrates meet commercial smelter specifications. The company reported very low deleterious elements and payable metals (including Pt, Pd, and expected payable Co, Ag, and Au), supporting a potential low-capital restart without an on-site smelter. NexMetals plans to incorporate results into a new mineral resource estimate in Q2 2026.

$ASTSLow

AST SpaceMobile Blacklift: 5 BlueBirds a Launch [2026]

AST SpaceMobile announced on November 6, 2026, plans to build a reusable rocket, Blacklift, to launch its BlueBird satellites. The 20-ton rocket, funded by a $1.3 billion deal with Firefly Aerospace, can carry up to five satellites per launch, with first flights targeted for late 2028. The company aims to control its launch schedule and reduce dependency on external providers.

$TSLAMedAI 8/10

Musk Says His Terafab Chip Plant Could Cost $1 Trillion

Elon Musk agreed with Ron Baron's estimate that Terafab, a chip venture of Tesla (TSLA) and SpaceX (SPCX), could cost $1 trillion. Musk set aggressive production targets but acknowledged risks. Tesla and SpaceX shares rose post-conference, and Intel (INTC) also gained. The first phase of Terafab is estimated at $16.8 billion, with later phases unfunded. Tesla's Q3 free cash flow fell 61.63%, while SpaceX guided Q4 capex to $35-40 billion.

$ASTSMedAI 8/10

Ton Rocket: What It Means for ASTS [2026]

AST SpaceMobile (ASTS) announced its Blacklift rocket, a 20-ton reusable vehicle to launch BlueBird satellites, with operations expected to start in late 2028. The company secured a $1.3 billion engine supply deal with Firefly Aerospace, aiming to reduce reliance on SpaceX. The rocket's specifications and reusability are not yet confirmed, and launch prices remain undisclosed.

$JNJHighAI 9/10

J&J posts trial win for psoriatic arthritis pill (JNJ:NYSE)

Johnson & Johnson (JNJ) reported that Icotyde, a therapy co-marketed with Protagonist Therapeutics (PTGX), showed success in a late-stage trial for psoriatic arthritis, according to the company. The drug is already FDA-approved for plaque psoriasis. Up to 30% of plaque psoriasis patients also develop psoriatic arthritis, per studies.